Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging roles of circular RNAs in osteoporosis. | J Cell Mol Med | 2021 | 34490735 | PubTator, text mining | PubMed |
| Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis. | Front Oncol | 2021 | 34490081 | PubTator, text mining | PubMed |
| Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis. | Front Immunol | 2021 | 34489932 | PubTator, text mining | PubMed |
| Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma. | Cancer Cell Int | 2021 | 34454479 | PubTator, text mining | PubMed |
| Circulating miRNAs Related to Epithelial-Mesenchymal Transitions (EMT) as the New Molecular Markers in Endometriosis. | Curr Issues Mol Biol | 2021 | 34449536 | PubTator, text mining | PubMed |
| Clinical Impact of Thrombus Aspiration and Interaction With D-Dimer Levels in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. | Front Cardiovasc Med | 2021 | 34447791 | PubTator, text mining | PubMed |
| LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs. | J Immunother Cancer | 2021 | 34446576 | PubTator, text mining | PubMed |
| Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors of Secondary Cardiovascular Events. | Biomedicines | 2021 | 34440258 | PubTator, text mining | PubMed |
| Expression of miRNAs Targeting ATP Binding Cassette Transporter 1 (ABCA1) among Patients with Significant Carotid Artery Stenosis. | Biomedicines | 2021 | 34440128 | PubTator, text mining | PubMed |
| Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan. | Biomedicines | 2021 | 34440064 | PubTator, text mining | PubMed |
| The Role of Immune-Related miRNAs in the Pathology of Kidney Transplantation. | Biomolecules | 2021 | 34439863 | PubTator, text mining | PubMed |
| The Emerging Role of Long Non-Coding RNAs and MicroRNAs in Neurodegenerative Diseases: A Perspective of Machine Learning. | Biomolecules | 2021 | 34439798 | PubTator, text mining | PubMed |
| Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver. | Evid Based Complement Alternat Med | 2021 | 34426744 | PubTator, text mining | PubMed |
| miR-33a-5p inhibits the progression of esophageal cancer through the DKK1-mediated Wnt/β-catenin pathway. | Aging (Albany NY) | 2021 | 34426559 | PubTator, text mining | PubMed |
| LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases. | Front Pharmacol | 2021 | 34421622 | PubTator, text mining | PubMed |
| Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. | J Hematol Oncol | 2021 | 34404434 | PubTator, text mining | PubMed |
| Circular RNAs in the Regulation of Oxidative Stress. | Front Pharmacol | 2021 | 34385919 | PubTator, text mining | PubMed |
| Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma. | J Exp Clin Cancer Res | 2021 | 34384473 | PubTator, text mining | PubMed |
| MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body. | Front Mol Biosci | 2021 | 34381815 | PubTator, text mining | PubMed |
| LncRNA GACAT1 induces tongue squamous cell carcinoma migration and proliferation via miR-149. | J Cell Mol Med | 2021 | 34378327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=38